| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
5am Partners VI, LLC is 10% Owner at CAMP and has filed Form 4s across 3 companies.
Historically, 5am Partners VI, LLC's trades have earned a below-average insider score of 43/100 across 7 rated trades. Over a 12-month horizon, 14.3% of those trades were profitable, with an average 12-month return of -37.0%.
The biggest single holding is ELVN (~$28.5M) as 10% Owner. The ELVN filings lean toward selling, a net 1,962,500 shares.
5am Partners VI, LLC has 8 Form 4 filings on record from August 2023 to August 2026, across 3 companies: 10% Owner at Camp4 Therapeutics (CAMP), 2024–2026; 10% Owner at Artiva Biotherapeutics (ARTV), 2024; 10% Owner at Enliven Therapeutics (ELVN), 2023–2024.
The 17 reported transactions were 8 open-market sales, 4 open-market purchases, 3 conversions and 2 other transactions.
Counted by filing, the open-market trades come to 3 purchases worth about $24.5M and 4 sales worth about $29.8M.
The largest open-market purchase was 833,333 shares of ARTV at an average $12.00 on July 22, 2024, about $10.0M. Twelve months later ARTV was down 78%.
The largest open-market sale was 825,000 shares of ELVN at an average $14.90 on February 14, 2024, about $12.3M. Twelve months later ELVN was up 25%.
None of the 4 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | CAMP Camp4 Therapeutics Corp | 10% Owner | Buy | 2,941,176 | $1.53 | $4,499,999.28 | New | +105.8% | +52.9% | |
| Oct 15, 2024 | CAMP Camp4 Therapeutics Corp | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +53.0% | -63.3% | -68.0% | |
| Jul 22, 2024 | ARTV Artiva Biotherapeutics, Inc. | 10% Owner | Buy | 833,333 | $12.00 | $9,999,996.00 | +239.0% | -11.0% | -78.1% | |
| Feb 14, 2024 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Sell | 825,000 | $14.90 | $12,292,500.00 | -56.5% | +39.0% | +25.2% | |
| Jan 31, 2024 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Sell | 500,000 | $15.00 | $7,500,000.00 | -39.3% | +10.8% | +35.5% | |
| Sep 26, 2023 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Sell | 197,500 | $15.00 | $2,962,500.00 | -18.8% | +1.5% | +69.8% | |
| Aug 24, 2023 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Sell | 440,000 | $16.00 | $7,040,000.00 | -33.1% | -33.0% | +35.2% |